 |
Immunomic Therapeutics
Last updated: October 11, 2024
CEO William G. Hearl
USA | Funding: $78.4M (+)
Website: https://www.immunomix.com
Immunomic Therapeutics is a development stage biotechnology company that develops lysosomal associated membrane protein-based vaccines.
Website: https://www.immunomix.com
Immunomic Therapeutics is a development stage biotechnology company that develops lysosomal associated membrane protein-based vaccines.
